Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363480
Status:
COMPLETED
Last Update Posted:
2018-03-09
First Post:
2006-08-10
Brief Title:
Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Asthma Control Assessment Via ACT and DRC in Asthmatics Treated With Seretide 50250 Over 12 Weeks
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The majority of asthma patients are not well controlled despite the availability of asthma medication that could effectively treat the disease In this study uncontrolled patients who are steroid-naive or on low dose inhaled corticosteroids will be treated with Seretide salmeterolfluticasone combination SFC 50250 µg twice daily The asthma control test ACT will be used to detect differences in the level of asthma control during treatment The study aims to show a correlation between improvements of ACT und the level of asthma control which will be reached by the patients
The aim of the study is to show that most of symptomatic asthma patients can reach well controlled asthma with SFC We get information about ACT in daily practice and physicians are trained to use the asthma control test as a screening tool and for follow up of asthma management Correlations are expected between the improvements in ACT Quality of Life and asthma control according to the Gaining Optimal Asthma controL GOAL criteria
The aim of the study is to show that most of symptomatic asthma patients can reach well controlled asthma with SFC We get information about ACT in daily practice and physicians are trained to use the asthma control test as a screening tool and for follow up of asthma management Correlations are expected between the improvements in ACT Quality of Life and asthma control according to the Gaining Optimal Asthma controL GOAL criteria
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None